Etiological risk factors for subfertility among Palestinian women in Gaza

Mhmoud Mohmmed Sirdh, Abdelnsser Kssem Abushhl Bh Yousif Ghlyeni,Ahmed Gmel AburmdnBiology Deprtment, Al Azhr University Gz Plestine;

bAlawda Maternity Hospital, Gaza, Palestine;

cAl Basma Fertility Center, Gaza, Palestine.

INTRODUCTION

Conception and pregnancy are complex proc-esses that include different biological aspects and phases.The most important things are the produc-tion of healthy sperms and eggs from the husband and wife's reproductive organs. The inability to conceive after at least one year of regular unprotected sexual intercourse can be due to different causes related to either partner or to both. In developing countries and especially in the Middle East, a high rate of childlessness is considered as one of the most important and underappreciated reproductive health problems[1,2]. The inability to procreate is considered a personal tragedy with considerable suffering for both partners, affecting the entire family and even local community, which may lead to severe psychosocial consequences[3,4]. In many cultures, including the Arabic oriental, womanhood is defined through motherhood, and infertile women usually carry, incorrectly, the responsibility for couple's inability to conceive or having a baby. Childless women are, unfortunately, commonly stigmatized,resulting in isolation, disregard and disrespect[5-8].

The World Health Organization (WHO)estimates that there were 60-80 million infertile couples worldwide with an incidence of 20% in the Eastern Mediterranean region and 11% in the developed world[9,10].In Palestine, there have been no documented reports or published scientific works that investigated the magnitude and etiological risk factors associated with subfertility. Moreover, the demographic records published by the Palestinian Central Bureau of Statistics revealed a significant decline in fertility rates of Palestine. The fertility rate declined from 6.1 births per woman in 1994 to 4.9 in 1999 and 4.6 in 2003 to 4.1 in 2008-2009[11]. As the considerably high prevalence of childlessness worldwide and especially in developing countries, we believed that the identification of etiological risk factors underlying each case is the key to successful treatment and problem solving for so many cases. The present work aimed for indentifying the etiological risk factors associated with subfertility among Palestinian women in Gaza.

SUBJECTS AND METHODS

Subjects

The present study took place in Gaza and the mentioned data represent cases from January 2006 to May 2010. The cases were selected randomly (simple random sampling)from 169 infertile women who attended the Al Basma Fertility Center for medical management of subfertility or other maternity issues. The Al Basma Fertility Center is located in Gaza city and offers its service to couples from all Gaza Strip localities. In addition, 115 healthy fertile women who attended public or private clinics for family planning issues were included as the control group. Women who received any medication or were subjected to surgery to achieve pregnancy were excluded from the control group. The study was performed in accordance with the ethical standards established in the 1964 and 1975 Declarations of Helsinki, and the modifications thereafter. The present study was approved and endorsed by the Ethical Committee at the Biology Department, Al Azhar University-Gaza. Informed consent was obtained from all women prior to their inclusion in the study.

Questionnaire interview

Parts of data were collected by using close-ended questionnaire which was constructed and conducted in Arabic language. The questionnaire was designed to include major components: socio-demographic and general characteristics; gynecological and obstetrics profile; other health characteristics; health complains and medical history of the subjects. The items and components of the questionnaire were validated at three levels including the criterion, content and piloting.

Ultrasonography

After the completion of questionnaire, women were clinically investigated by gynecologists for the status of the reproductive system using ultrasoundbased diagnostic imaging technique. Ultrasonography was conducted by using an Aloka SSD-1000 Ultrasound (Aloka, Tokyo, Japan). Ultrasonography provided an evaluation of the anatomical characteristics of the female reproductive system. The main points of interest were the size of the uterus, presence of myoma, the state of the endometrium, polycystic ovary syndrome, the presence of hydrosalpinges and cysts or ovarian neoplasm.

Infections

Gynecologists also evaluated the women for different causes of vaginal infections using high vaginal swabs, which are helpful for the diagnosis of bacterial vaginosis and vaginal candidiasis. The high vaginal swab technique included a sterile swab that was inserted into the vaginal posterior fornix while care was taken to avoid the lower vaginal walls[12]. The swabs were used for identifying the causative microorganisms of vaginal infection by using culture technique.In addition, fresh mid-urine specimens were investigated microscopically for microbiological infections.For infection with Toxoplasma gondii, venous blood samples were withdrawn and serum was tested for specific IgM antibodies by using ELISA test kit (Teco Diagnostics, Anaheim, CA, USA)following the manufacturer's instructions.

Hormonal analysis

By using commercially available kits (Tosoh Bioscience, San Francisco, CA, USA)and according to the manufacturer's instructions, venous blood from the subjects was tested for the following hormones,including prolactin, follicle stimulating hormone(FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH)and anti-mullerian hormone (AMH).Any change from the normal ranges provided in the instruction manual of Tosoh Biosciences kits was considered as hormonal abnormality.

Table 1 Socio-demographic characteristics of the subjects

Thrombophilic profile

In addition, the women were investigated for heterozygosity or homozygosity in one or more of the three common genes affecting the coagulation factors in the clotting cascades. The polymorphism was investigated by PCR/RFLP. The investigated gene variants were MTHFR 677 C > T and digested by HinfI, factor V Leiden 1691 G > A digested by MnlⅠand prothrombin 20210 G > A digested by HindⅢ. The molecular methodologies were as described elsewhere[13-15]. For cost-effectiveness purpose, it was worthwhile to mention that, in the control group, we only screened 35 randomly selected samples for the polymorphism in the included thrombophilic genes.

Statistical analysis

The frequencies of different categorical variables among subfertile women and fertile women in the control group were summarized as numbers and frequencies and compared by using χ2tests. The association between subfertility and variables were assessed using a univariate simple logistic regression and reported as crude odds ratios (OR)with 95% confidence intervals (95% CI). Statistically significant predictor variables with P value less than 0.05 in the univariate analysis were included in the multiple logistic regression model to examine the risk factors that were potentially associated with subfertility in our Palestinian cohort. The results from the multiple logistic regression were presented as adjusted odds ratio (aORs)with 95% CI. P values were two sided, and P < 0.05 was considered to indicate statistical significance. All analyses were performed by using the SPSS statistical package version 13.0 (SPSS Inc, Chicago, IL, USA).

RESULTS

The results showed that 73.5 % (169/230)of the women who attended gynecology clinics sought treatment for subfertility and 26.5% (61/230)sought treatment for recurrent miscarriages. The mean age of subfertile women was 27.5±5.7 years, and 75.1 %of them were≤30 years old. Statistically significant differences were noted in the prevalence of subfertility between different localities of Gaza. The percentage of subfertility in urban areas was significantly higher than that of rural areas (P < 0.001)(Table 1). Moreover, the results revealed significant differences with regard to career (P = 0.025): the percentage of subfertility among career women was significantly higher than that of non-career women while no significant differences (P = 0.504)were reported with regard to educational level.

The evaluation of menstrual cycle and the female reproductive system is illustrated in Table 2. Significantly higher percentages of women with irregular menstrual cycle and period < 5 days were reported in the subfertile group (10.1% and 12.4%)as compared to the control group (3.5% and 5.2%), with P values of 0.04 and 0.048, respectively, while no significant differences were reported for the severity/heaviness of menstruation (P = 0.083).

In addition, the percentage of subfertile women(18.3%)with retroverted uterus was significantly higher than that in the control group (2.6%)(P <0.0001). The percentages of women with polycystic ovary syndrome and abnormities in fallopian tubes were also significantly higher in the subfertility group than those of the control group (P < 0.001). On the other hand, no significant differences were noted in the prevalence of endometriosis between the subfertile and control group (P = 0.148).

The classification of the study population according to the presence of abnormalities in one or more of fertility-related hormones (sex hormones and TSH)are presented in Table 3. Hormonal abnormities were significantly higher in the subfertile group as compared to the control group. In addition, the percentages of women with a family history of subfertility, women with vaginal infections and women with chlamydia were significantly higher in subfertile women as compared to the control group while no significant differences were observed regarding urinary tract infections or toxoplasmosis (P > 0.05).

Table 2 Characteristics of menstruation and the female reproductive system of the study subjects

Table 4 shows the distributions of some common thrombophilic abnormalities among the study population, which were also shown as an overall prevalence of thrombophilic disorders for the cases and controls.The overall prevalence of thrombophilic disorders was not a mathematical sum of the prevalence of individual polymorphisms, as one sample may contain one or more polymorphisms. About 30.2% of the women in the subfertile group exhibited one or more of the thrombophilic disorders screened. These percentages were significantly higher when compared to those of the control group (P = 0.022). The detailed distributions of the thrombophilic disorders among the cases are also presented.

We performed univariate statistical analysis to study the association between the various exposures,if any, with the fertility state (subfertility versus fertile controls). In this unadjusted analysis, we calculated the crude ORs and their 95% CI, which are shown in Table 5. In this analysis, the following factors: women's educational level, heaviness of menstruation, endometriosis, urinary tract infection, and toxoplasmosis showed no significant associations. As a result, our multivariate analysis was adjusted to contain fewer potential risk factors. After adjustment of the potential confounding factors as a result of the univariate analysis, we undertook a multivariate statistical analysis in order to calculate the aOR and their 95% CI aiming to identify the etiological risk factors associated to subfertility in our cohort of Palestinian women. The multiple logistic regression analysis for all cases and controls provided nearly similar results (Table 6)to the unadjusted analyses except for three factors, including family history, irregularity of menstruation and thyroid stimulating hormone abnormalities.

Table 3 Medical characteristics of the subjects

Table 4 Prevalence of thrombophilic disorders among the subjects

DISCUSSION

This is the first study that attempts to highlight possible etiological risk factors among subfertile Palestinian women in Gaza where Arabic and oriental traditions andcustoms control the attitudes of society. In this study, we aimed not only to present the frequencies of factors that may possibly cause subfertility, but also to provide a more useful elucidation of the attributable risks in terms of the whole population from the public health perspective. Therefore, we used the univariate and multivariate statistical analyses and provided the crude and adjusted OR and their 95% CI, which allow health epidemiologists to calculate what percentage of a disease could possibly be prevented if an etiological risk factor could be removed or decreased from the population.

Table 5 Univariate analysis: crude ORs and their 95% CI

Table 6 Multivariate analysis: aOR and their 95% CI for risk factors associated with subfertility

The most frequent etiological risk factors for subfertility among Palestinian women in Gaza were thrombophilic disorders (aOR = 21.42, 95% CI, 6.80-67.51, P = 0.001), fallopian tube problems (aOR =13.63, 95% CI, 1.43-129.81, P = 0.023), sex hormones abnormalities (aOR = 11; 95% CI, 69 3.82-35.80, P =0.001)and polycystic ovary syndrome (aOR = 10.29,95% CI, 1.88-56.10, P = 0.007). When these etiological risk factors were discussed in terms of aOR, in addition to prevalence, the magnitude of these factors became more disquieting and frightening. Women with thrombophilic disorders were about 21 times more likely to be subfertile than those with normal thrombophilic profile. The same is true for fallopian tube damage, sex hormones abnormalities and polycystic ovary syndrome.

The present study investigated the thrombophilic profile of subfertile women and the results highlighted the importance of these disorders in developing subfertility in Gaza women. In our cohort, thrombophilic disorders ranked first as a major etiological factor for subfertility among Palestinian women at the Gaza Strip. The results revealed that women with thrombophilic disorders are about 21 times more likely to be subfertile than those with normal thrombophilic profile. Therefore, testing and managing these thrombophilic disorders in women before conception are highly recommended. The crucial effects of thrombophilic disorders on conception and pregnancy outcome have been addressed properly in previous investigations[16-21]. Fatini et al. demonstrated that a significant relationship between inherited thrombophilia and unexplained infertility in 930 infertile females of Caucasian origin, thus suggesting the contribution of genetic components in modulating unexplained infertility[22]. Thus, several subfertile women cases in Gaza could be therapeutically managed by correcting or adjusting their coagulation profile before and during the childbearing period. However, Casadei et al. found no significant difference in the prevalence of three thrombophilic mutations (MTHFR 677 C > T;Factor V Leiden 1691 G > A and prothrombin 20210 G > A)between 100 infertile women with unexplained infertility as compared with 200 control fertile women without a history of infertility[23].

Fallopian tube problems and sex hormone abnormalities ranked second and third as major etiological risk factors for subfertility among Gaza women,respectively. Thus, several subfertile women cases in Gaza could be managed before the planning of childbearing. Studies addressing fallopian tube problems,sex hormone abnormalities and polycystic ovary syndrome as major risk factors for subfertility in other populations and settings are abundant[24-30]. Some of the risk factors addressed by the present work have been documented in previous studies. In our study,retroverted uterus and vaginal infections are among the etiological risk factors of subfertility, while infection with chlamydia, the presence of toxoplasmosis and urinary tract infections are not among significant risk factors in our cohort. The published data about the association between urogenital infections and female subfertility are conflicting. A study of 622 infertile and 495 fertile women failed to detect a relationship between toxoplasmosis and female subfertility[31],while the study by Li et al. of 882 subfertile and 107 fertile women revealed a significant difference in the seroprevalence of toxoplasmosis antibodies between subfertile (15.9%)and fertile women (5.6%)[32]. The negative impact of genital chlamydia trachomatis infections on female fertility has been well documented in previous studies and reviews[33-35].

El Hakim et al.[36]showed a direct association between chlamydia antibody titer and the severity of tubal damage in subfertile women. Cytomegalovirus infection has been associated wtih female subfertility[37];however, the study by Mahdi et al. failed to reveal a significant difference between the infertile and control group regarding cytomegalovirus infection[38].

Moreover, hormonal abnormalities and urban life style were considered as risk factors in our study.Damti et al. hypothesized that alternation of cortisol excretion patterns along the menstrual cycle due to stress eventually affects women's hormonal profile in the critical stages of child bearing age[25]. In our study,many subfertile women were found to have a combination of different etiological factors. Therefore, it is the responsibility of gynecologists to consider the etiological risk factors mentioned in the present work during their evaluation of patients. Finding one risk factor, even a major risk factor, does not by any means restrict the seeking for other risk factors.

It is concluded that subfertility among Palestinian women of Gaza is a multi-factorial condition where several possible etiological factors could be recognized. High risk and lower risk factors were reported and should be considered during managing subfertile women for hopeful conception. Therefore, comprehensive evaluation for women should be a strategic approach; otherwise, waiting for motherhood will be longer or conception may never take place.

[1]Bergström S. Reproductive failure as a health priority in the Third World: a review. East Afr Med J 1992; 69:174-80.

[2]Leke RJ, Oduma JA, Bassol-Mayagoitia S, Bacha AM,Grigor KM. Regional and geographical variations in infertility: effects of environmental, cultural, and socioeconomic factors. Environ Health Perspect 1993; 101(S2): 73-80.

[3]Daar AS, Merali Z. Infertility and social suffering: the case of ART in developing countries. In: Vayena E,Rowe PJ, Griffin PD, Editors. Current Practices and Controversies in Assisted Reproduction. Geneva, Switzerland: World Health Organization; 2002. 15-21.

[4]Dyer S, Lombard C, Van der Spuy Z. Psychological distress among men suffering from couple infertility in South Africa: a quantitative assessment Hum Reprod 2009; 24: 2821-6.

[5]Gerrits T. Social and cultural aspects of infertility in Mozambique. Patient Educ Couns. 1997; 31: 39-48.

[6]Papreen N, Sharma A, Sabin K, Begum L, Ahsan SK,Baqui AH. Living with infertility: experiences among Urban slum populations in Bangladesh. Reprod Health Matters 2000; 8: 33-44.

[7]Richards SC. "Spoiling the womb": definitions, aetiologies and responses to infertility in north west province,Cameroon. Afr J Reprod Health. 2002; 6: 84-94.

[8]Wiersema NJ, Drukker AJ, Mai BT, Giang HN, Nguyen TN, Lambalk CB. Consequences of infertility in developing countries: results of a questionnaire and interview survey in the South of Vietnam. J Transl Med 2006; 4:54.

[9]Fathalla MF, Sinding SW, Rosenfield A, Fathalla MM.Sexual and reproductive health for all: a call for action.Lancet. 2006; 368: 2095-100.

[10]Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatmentseeking: potential need and demand for infertility medical care. Hum Reprod. 2007; 22: 1506-12.

[11]Palestinian Central Bureau of Statistics: On the Eve of the International population Day 11/07/2012-Press Release Ramallah, Palestine; 2012. http://www.pcbs.gov.ps/Portals/_pcbs/PressRelease/int_Pop_2012e.pdf

[12]King Edward Memorial Hospital. Low vaginal, high vaginal, endocervical and rectal swabs clinical guidelines section a: guidelines relevant to obstetrics and gynecology. 2012.

[13]Bertina RM, Koeleman BP, Koster T, Rosendaal FR,Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.

[14]Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA,Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10: 111-3.

[15]Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996; 88: 3698-703.

[16]Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage.Am J Reprod Immunol. 2006; 55: 360-8.

[17]Coulam CB, Jeyendran RS. Thrombophilic gene polymorphisms are risk factors for unexplained infertility.Fertil Steril 2009; 91(S4):1516-7.

[18]Baré SN, Póka R, Balogh I, Ajzner E. Factor V Leiden as a risk factor for miscarriage and reduced fertility.Aust N Z J Obstet Gynaecol. 2000; 40: 186-90.

[19]Qublan HS, Eid SS, Ababneh HA, Amarin ZO, Smadi AZ, Al-Khafaji FF, et al. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum Reprod. 2006; 21: 2694-8.

[20]Behjati R, Modarressi MH, Jeddi-Tehrani M, Dokoohaki P, Ghasemi J, Zarnani AH, et al. Thrombophilic mutations in Iranian patients with infertility and recurrent spontaneous abortion. Ann Hematol.. 2006; 85: 268-71.

[21]Azem F, Many A, Ben Ami I, et al. Increased rates of thrombophilia in women with repeated IVF failures.Hum Reprod. 2004; 19(2): 368-70.

[22]Fatini C, Conti L, Turillazzi V, Sticchi E, Romagnuolo I,Milanini MN, et al. Unexplained infertility: association with inherited thrombophilia. Thromb Res 2012; 129:e185-8.

[23]Casadei L, Puca F, Privitera L, Zamaro V, Emidi E. Inherited thrombophilia in infertile women: implication in unexplained infertility. Fertil Steril 2010; 94: 755-7.

[24]van Balen F, Verdurmen JE, Ketting E. [Age, desire for children and probability of pregnancy in The Netherlands]. Ned Tijdschr Geneeskd 1995; 139: 792-6.

[25]Damti OB, Sarid O, Sheiner E, Zilberstein T, Cwikel J.Stress and distress in infertility among women. Harefuah. 2008; 147: 256-60.

[26]Jakubowski L. Genetic aspects of polycystic ovary syndrome. Endokrynol Pol 2005; 56: 285-93.

[27]Allahbadia GN, Merchant R. Fallopian tube recanalization: lessons learnt and future challenges. Womens Health (Lond Engl). 2010; 6: 531-48.

[28]Kitilla T. Hysterosalpingography in the evaluation of infertility: a five years review. (FGAE, 2001-5). Ethiop Med J 2010; 48: 267-75.

[29]Holoch KJ, Lessey BA. Endometriosis and infertility.Clin Obstet Gynecol 2010; 53: 429-38.

[30]Okeke TC, Ikeako LC, Ezenyeaku CC. Endometriosis.Niger J Med 2011; 20(2): 191-9.

[31]Aral Akarsu G, Elhan HA, Akarsu C. Retrospective evaluation of Toxoplasma gondii seropositivity in fertile and infertile women. Mikrobiyol Bul 2011; 45: 174-80.

[32]Li S, Cui L, Zhao J, Dai P, Zong S, Zuo W, et al. Seroprevalence of Toxoplasma gondii infection in female sterility patients in China. J Parasitol 2011; 97: 529-30.

[33]Bebear C, de Barbeyrac B. Genital Chlamydia trachomatis infections. Clin Microbiol Infect 2009; 15: 4-10.

[34]Akande V, Turner C, Horner P, Horne A, Pacey A. Impact of Chlamydia trachomatis in the reproductive setting: British Fertility Society Guidelines for practice.Hum Fertil (Camb)2010; 13: 115-25.

[35]Paavonen J, Eggert-Kruse W. Chlamydia trachomatis:impact on human reproduction. Hum Reprod Update 1999; 5: 433-47.

[36]El Hakim EA, Gordon UD, Akande VA. The relationship between serum Chlamydia antibody levels and severity of disease in infertile women with tubal damage. Arch Gynecol Obstet 2010; 281:727-33.

[37]Yang YS, Ho HN, Chen HF, Chen SU, Shen CY, Chang SF, et al. Cytomegalovirus infection and viral shedding in the genital tract of infertile couples. J Med Virol 1995;45: 179-82.

[38]Mahdi B, Saour M, Salih W. Cytomegalovirus infection in infertile women. J Exp Integr Med. 2011; 1: 273-6.